A dynamic COVID-19 immune signature includes associations with poor prognosis

Laing, Adam G., Lorenc, Anna, del Molino del Barrio, Irene, Das, Abhishek, Fish, Matthew, Monin, Leticia, Muñoz-Ruiz, Miguel, McKenzie, Duncan R. +42 more·2020·Nature Medicine
DOI 10.1038/s41591-020-1038-6

Cited by (953)

Items 601–700 of 953

  1. Functionality of immune cells in COVID-19 infection: development of cell-based therapeutics
    Maryam Sayahinouri, Sahar Mashayekhi Firouz, Amin Ebrahimi Sadrabadi, Mina Masoudnia, Mahnaz Abdolahi, Fatemeh Jafarzadeh, Meshkat Nouripour, Sana Mirzazadeh, Nazanin Zangeneh, Arsalan Jalili et al. · 2023 · Bioimpacts
  2. Emerging opportunities to treat idiopathic pulmonary fibrosis: Design, discovery, and optimizations of small-molecule drugs targeting fibrogenic pathways
    Wenxin Luo, Yilin Gu, Siyu Fu, Jiaxing Wang, Jifa Zhang, Yuxi Wang · 2023 · European Journal of Medicinal Chemistry
  3. Point-of-care biomarker assay for rapid multiplexed detection of CRP and IP-10
    Claire Wilson, Bhavya Vashi, Pavol Genzor, Melissa K. Gregory, Jason Yau, Lauren Wolfe, Michael J. Lochhead, Philip J. Papst, Kristen Pettrone, Paul W. Blair et al. · 2023 · SLAS TECHNOLOGY
  4. High-dimensional phenotyping of the peripheral immune response in community-acquired pneumonia
    Tom D. Y. Reijnders, Alex R. Schuurman, Jan Verhoeff, Marlous van den Braber, Renée A. Douma, Daniel R. Faber, A Paul, Willem Joost Wiersinga, Anno Saris, Juan Jesús García-Vallejo et al. · 2023 · Frontiers in Immunology
  5. Characterization and trajectories of hematological parameters prior to severe COVID-19 based on a large-scale prospective health checkup cohort in western China: a longitudinal study of 13-year follow-up
    Yifei Lin, Yong Yang, Nanyan Xiang, Le Wang, Tao Zheng, Xuejun Zhuo, Rui Shi, Xiaoyi Su, Yan Liu, Ga Liao et al. · 2024 · BMC Medicine
  6. Vγ9Vδ2 T-cells Are Potent Inhibitors of SARS-CoV-2 Replication and Represent Effector Phenotypes in Patients With COVID-19
    Laëtitia Gay, Marie-Sarah Rouviére, Soraya Mezouar, Manon Richaud, Laurent Gorvel, Etienne D. Foucher, Bernard La Scola, Amélie Menard, Jérôme Allardet-Servent, Philippe Halfon et al. · 2024 · The Journal of Infectious Diseases
  7. Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients
    Andrea Sacconi, Claudia De Vitis, Luisa de Latouliere, Simona Di Martino, Francesca De Nicola, Frauke Goeman, Carla Mottini, Francesca Paolini, Michela D’Ascanio, Alberto Rícci et al. · 2021 · Cell Death and Disease
  8. Kinetics of SARS-CoV-2-Neutralising Antibodies of Residents of Long-Term Care Facilities
    Julien Moyet, François Helle, Gwladys Bourdenet, C. Joseph, Brigitte Gubler, Guillaume Deschasse, Isabelle Defouilloy, Tomislav Slovenski, Catherine François, Sophie Liabeuf et al. · 2021 · The journal of nutrition health & aging
  9. Evaluation of I-TAC as a potential early plasma marker to differentiate between critical and non-critical COVID-19
    Yushan Zhang, Chao Xu, Nelson Iván Agudelo Higuita, Resham Bhattacharya, Jennifer Holter Chakrabarty, Priyabrata Mukherjee · 2021 · Cell Stress
  10. SARS-CoV-2-Specific Memory B Cell Responses Are Maintained After Recovery from Natural Infection and Postvaccination
    Tom Moore, Rojony Hossain, Katie J. Doores, Manu Shankar‐Hari, David J. Fear · 2022 · Viral Immunology
  11. Cellular Immune Profiling of Lung and Blood Compartments in Patients with SARS-CoV-2 Infection
    Letizia Santinelli, Alessandro Lazzaro, Francesca Sciarra, Luca Maddaloni, Federica Frasca, Matteo Fracella, Sonia Moretti, Alessândra Borsetti, Ginevra Bugani, Francesco Alessandri et al. · 2023 · Pathogens
  12. SARS-CoV-2 RNAemia and proteomic biomarker trajectory inform prognostication in COVID-19 patients admitted to intensive care
    Manuel Mayr, Clemens Gutmann, Kaloyan Takov, Sean Anthony Burnap, Bhawana Singh, Konstantinos Theofilatos, Ella Reed, Maria Hasman, Adam Nabeebaccus, Matthew Fish et al. · 2020
  13. Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophages
    Suzanne Pickering, Harry Wilson, Enrico Bravo, Marianne R. Perera, Jeffrey Seow, Carl Graham, Nathalia Almeida, Lazaros Fotopoulos, Thomas Williams, Atlanta Moitra et al. · 2024 · Nature Communications
  14. Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants
    Hye Won Kwak, Hyo‐Jung Park, Seoyeon Jung, Eun Young Oh, Sang‐In Park, Yeon‐Hwa Kim, Hyeong-Jun Park, Sohyun Park, You-Jin Kim, Hae Li Ko et al. · 2023 · Vaccine
  15. Post–COVID-19 Afferent Baroreflex Failure
    Khaled Elkholey, Amr Wahba, Sachin Y. Paranjape, Mohammad Saleem, Annet Kirabo, Karen M. Joos, André Diedrich, Cyndya A. Shibao, Italo Biaggioni · 2023 · Hypertension
  16. Validation of reference gene stability for miRNA quantification by reverse transcription quantitative PCR in the peripheral blood of patients with COVID-19 critical illness
    Amanda Formosa, Erica Acton, Amy Huei‐Yi Lee, Paul J. Turgeon, Shehla Izhar, Pamela J. Plant, Jim N. Tsoporis, Sabri Soussi, Uriel Trahtemberg, ANDREW J. BAKER et al. · 2023 · PLoS ONE
  17. Humoral and cellular immune responses against SARS-CoV-2 post-vaccination in immunocompetent and immunocompromised cancer populations
    Elizabeth Titova, Veronica W. Kan, Tara Lozy, Andrew Ip, Kileen L. Shier, Vittal P. Prakash, Meghan W. Starolis, Sara Ansari, Kira Goldgirsh, Seoyeon Kim et al. · 2024 · Microbiology Spectrum
  18. Conventional and unconventional T-cell responses contribute to the prediction of clinical outcome and causative bacterial pathogen in sepsis patients
    Ross J. Burton, Loïc Raffray, Linda Moet, Simone M. Cuff, Daniel Allan White, Sarah E Baker, Bernhard Moser, Valerie B. O’Donnell, Peter Ghazal, Matt P. G. Morgan et al. · 2024 · Clinical & Experimental Immunology
  19. The role of hematological parameters in asymptomatic and non-severe cases of Omicron variant infection
    Suqin Ben, Fengying Gao, Ziheng Xu, Rulin Zhang, Xingyi Zhang, Ning Wang, Min Zhang, Lili Hou · 2024 · Virology Journal
  20. Immune signature of patients with cardiovascular disease predicts increased risk for a severe course of COVID‐19
    Manina Günter, Karin Anne Lydia Mueller, Mathew J. Salazar, Sarah Gekeler, Carolin Prang, Tobias Harm, Meinrad Gawaz, Stella E. Autenrieth · 2024 · European Journal of Immunology
  21. Altered baseline immunological state and impaired immune response to SARS-CoV-2 mRNA vaccination in lung transplant recipients
    Mengyun Hu, Ana Paula B N Oliveira, Zhuoqing Fang, Yupeng Feng, Molly Miranda, Sangeeta Kowli, Prabhu S. Arunachalam, Gowri Vasudevan, Harold Sai-yin Hui, Alba Grifoni et al. · 2025 · Cell Reports Medicine
  22. Identifying High-Risk Bacteria with Active Nasal Swab Surveillance in Intensive Care Units to Prevent Ventilator-Associated Pneumonia
    Yu Kuramasu, Yu Suzuki, Daisuke Akaneya, Yoshikazu Okuma, Yuta Tsujimoto, Daisuke Ishizawa, Kyoji Moriya, Parichart Hongsing, Mohan Amarasiri, Cameron Paul Hurst et al. · 2025 · International Journal of Translational Medicine
  23. Biomarkers for the clinical development of antiviral therapies
    Teresa I. Ng, Patrick K. Dorr, Preethi Krishnan, Daniel E. Cohen, Susan M. Rhee, Stanley X. Wang, Melanie C. Ruzek, Federico Mensa, Warren M. Kati · 2020 · Cytometry Part B Clinical Cytometry
  24. Comparisons of the immunological landscape between COVID-19, influenza, and respiratory syncytial virus patients by clustering analysis
    Zeinab Abdelrahman, Zuobing Chen, Haoyu Lyu, Xiaosheng Wang · 2021 · Computational and Structural Biotechnology Journal
  25. Early Cellular and Humoral Responses Developed in Oncohematological Patients after Vaccination with One Dose against COVID-19
    Sara Rodríguez-Mora, Magdalena Corona, Montserrat Torres, Guiomar Casado‐Fernández, Javier García‐Pérez, Fernando Ramos-Martín, Lorena Vigón, Mario Manzanares, Elena Mateos, Fernando Martín‐Moro et al. · 2022 · Journal of Clinical Medicine
  26. Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue Localization
    Antonio Bertoletti, Nina Le Bert, Anthony Tanoto Tan · 2022 · International Journal of Molecular Sciences
  27. Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19
    Deblina Raychaudhuri, Purbita Bandopadhyay, Ranit D’Rozario, Jafar Sarif, Yogiraj Ray, Shekhar Ranjan Paul, Praveen Singh, Kausik Chaudhuri, Ritwik Bhaduri, Rajesh Pandey et al. · 2022 · Mayo Clinic Proceedings Innovations Quality & Outcomes
  28. A 9-mRNA signature measured from whole blood by a prototype PCR panel predicts 28-day mortality upon admission of critically ill COVID-19 patients
    Claire Tardiveau, Guillaume Monneret, Anne‐Claire Lukaszewicz, Valérie Cheynet, Elisabeth Cerrato, Katia Imhoff, Estelle Peronnet, Maxime Bodinier, Louis Kreitmann, Sophie Blein et al. · 2022 · Frontiers in Immunology
  29. The risk of COVID-19 can be predicted by a nomogram based on m6A-related genes
    Lingling Lu, Yijing Li, Xiulan Ao, Jiaofeng Huang, Bang Liu, Liqing Wu, Dongliang Li · 2022 · Infection Genetics and Evolution
  30. It’s in the blood: a review of the hematological system in SARS-CoV-2-associated COVID-19
    James V. Harte, Caroline Coleman-Vaughan, Maeve P. Crowley, Vitaliy Mykytiv · 2023 · Critical Reviews in Clinical Laboratory Sciences
  31. A Study of how the Serum Levels of Inflammatory Markers Correlate with Hemoglobin Oxygen Saturation Percentage and the Type of Respiratory Support Received by Covid-19 Patients Hospitalized in Intensive Care Units
    Ali Moghadaci, Sam Saghari, Zahra Abbasi, Mohammad Arad Zandieh, Mohammad Hossein Gholami, Kiavash Hushmandi, Abdolqayum Movahedi Rudi, Rasoul Raesi · 2024 · The Open Public Health Journal
  32. Response to a massive SARS-CoV-2 infection in a nursing home transformed into a caring center
    Paolo Agostinis, Valentina Vianello, Elena Dereani, Giuseppe Caruso, Beatrice Montessoro, Marco Taurian, Antonio Di Chiara, Vincenzo Patruno, Francesco Cavallin, Gian Paolo Fadini et al. · 2021 · Aging Clinical and Experimental Research
  33. Identification of COVID-19 subtypes based on immunogenomic profiling
    Zuobing Chen, Qiushi Feng, Tianfang Zhang, Xiaosheng Wang · 2021 · International Immunopharmacology
  34. A Virus-Specific Immune Rheostat in the Immunome of Patients Recovering From Mild COVID-19
    Joo Guan Yeo, Jing Yao Leong, Shi Huan Tay, Karen Donceras Nadua, Danielle E. Anderson, Amanda Jin Mei Lim, Xiang Wen Ng, Su Li Poh, Dianyan Guo, Katherine Nay Yaung et al. · 2021 · Frontiers in Immunology
  35. Immunometabolic analysis shows a distinct cyto-metabotype in Covid-19 compared to sepsis from other causes
    Francesca Maria Trovato, Salma F. Mujib, Ellen Jerome, Anna Cavazza, Phillip Edgar Morgan, John Smith, Maria Therese Depante, Kevin O'Reilly, James Luxton, Tracey Anne Mare et al. · 2022 · Heliyon
  36. Impact of Innate Immunity, Endothelial Damage, and Metabolic Biomarkers on COVID-19 Severity and Mortality
    Joseph M. Rocco, Paola Laghetti, Mariantonietta Di Stefano, Irini Sereti, Ana Maria Ortega‐Villa, Jing Wang, Adam W. Rupert, Maria Chironna, Peiying Ye, Xiangdong Liu et al. · 2022 · Open Forum Infectious Diseases
  37. Machine learning of flow cytometry data reveals the delayed innate immune responses correlate with the severity of COVID-19
    Jing Zhu, Tunan Chen, Xueying Mao, Yitian Fang, Heqi Sun, Dong‐Qing Wei, Guang‐Fu Ji · 2023 · Frontiers in Immunology
  38. COVID-19: The Disease, the Immunological Challenges, the Treatment with Pharmaceuticals and Low-Dose Ionizing Radiation
    Jihang Yu, Edouard I. Azzam, Ashok B. Jadhav, Yi Wang · 2021 · Cells
  39. Deep immune profiling of the maternal-fetal interface with mild SARS-CoV-2 infection
    Suhas Sureshchandra, Michael Z. Zulu, Brianna M. Doratt, Allen Jankeel, Delia F. Tifrea, Robert A. Edwards, Monica P. Rincon, Nicole Marshall, Ilhem Messaoudi · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Disease trajectories in hospitalized COVID-19 patients are predicted by clinical and peripheral blood signatures representing distinct lung pathologies
    João Luiz Silva‐Filho, Vanessa Herder, Matthew P. Gibbins, Monique Freire dos Reis, Gisely Cardoso de Melo, Michael Haley, Carla C. Judice, Fernando Val, Mayla Gabriela Silva Borba, Tatyana Almeida Tavella et al. · 2023 · medRxiv
  41. Cytokine and Chemokine Levels in COVID-19 Convalescent Plasma
    Tania S. Bonny, Eshan U. Patel, Xianming Zhu, M. Grabowski, Kirsten E. Littlefield, Oliver B Laeyendecker, Arturo Casadevall, Aaron A.R. Tobian · 2020 · Open Forum Infectious Diseases
  42. Current clinical findings of acute neurological syndromes after SARS‐CoV‐2 infection
    Minjin Wang, Jierui Wang, Yan Dong Ren, Lu Lu, Weixi Xiong, Lifeng Li, Lin Xu, Meng Tang, Yushang Yuan, Yi Xie et al. · 2024 · MedComm
  43. SARS-CoV-2 and UPS with potentials for therapeutic interventions
    Jannatul Ferdoush, Rizwaan Abdul Kadir, Selin Kaplanoğlu, Morgan Osborn · 2024 · Gene
  44. Bioinformatics and molecular biology tools for diagnosis, prevention, treatment and prognosis of COVID-19
    Débora Dummer Meira, Aléxia Stefani Siqueira Zetum, Matheus Correia Casotti, Danielle Ribeiro Campos da Silva, Bruno Cancian de Araújo, Creuza Rachel Vicente, Daniel de Almeida Duque, Bianca Paulino Campanharo, Fernanda Mariano Garcia, Camilly Victória Campanharo et al. · 2024 · Heliyon
  45. The IL-6 hypothesis in COVID-19: A phase 2, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of free IL-6 sequestration by the monoclonal antibody sirukumab in severe and critical COVID-19
    Robert Gottlieb, Meredith E. Clement, Paul Cook, Audra Deveikis, Kap Sum Foong, Philip Robinson, Jihad Slim, Cedric W. Spak, Annemie Buelens, Katleen Callewaert et al. · 2024 · Journal of Infection
  46. Antibody and viral RNA kinetics in SARS-CoV2 infected patients admitted to a Romanian University Hospital of Infectious Diseases
    Amanda Lelia Rădulescu, Alexandru Istrate, Mirela Flonta, Mihaela Sorina Lupșe · 2021 · International Journal of Infectious Diseases
  47. Sex differences in immunological responses to COVID-19: a cross-sectional analysis of a single-centre cohort
    Nishkantha Arulkumaran, Timothy Arthur Chandos Snow, Adarsh Kulkarni, David A. Brealey, Hannah M. Rickman, Chloe Rees-Spear, Moira J. Spyer, Judith Heaney, Edmund Garr, Bryan Williams et al. · 2021 · British Journal of Anaesthesia
  48. Case Report: Severe COVID-19 with Late-Onset Sepsis-like Illness in a Neonate
    Suryadi Nicolaas Napoleon Tatura · 2022 · American Journal of Tropical Medicine and Hygiene
  49. RETRACTED: The pathogenicity of COVID-19 and the role of pentraxin-3: An updated review study
    Ria Margiana, Satish Kumar Sharma, Bilal Irshad Khan, Ameer A. Alameri, Maria Jade Catalan Opulencia, Ali Thaeer Hammid, Thulfeqar Ahmed Hamza, Бабакулов Шараф Хамракулович, Walid Kamal Abdelbasset, Zanko Hassan Jawhar · 2022 · Pathology - Research and Practice · Retracted
  50. Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2
    Xiaohui Wei, Na Rong, Jiangning Liu · 2022 · Frontiers in Immunology
  51. An untargeted metabolomic approach to investigate antiviral defence mechanisms in memory leukocytes secreting anti-SARS-CoV-2 IgG in vitro
    Federica Gevi, Giuseppina Fanelli, Veronica Lelli, Zarletti Gianpaolo, Massimo Tiberi, Veronica De Molfetta, Giuseppe Scapigliati, Timperio Anna Maria · 2023 · Scientific Reports
  52. Immune cell landscape in symptomatic and asymptomatic SARS-CoV-2 infected adults and children in urban Dhaka, Bangladesh
    Evana Akhtar, Akhirunnesa Mily, Protim Sarker, Bikash Chandra Chanda, Farjana Haque, Rakib Ullah Kuddusi, Md. Ahsanul Haq, Magda Lourda, Susanna Brighenti, Rubhana Raqib · 2023 · Immunobiology
  53. Genetic signature detected in T cell receptors from patients with severe COVID-19
    Manuel Corpas, Carmen de Mendoza, Víctor Moreno‐Torres, Ilduara Pintos-Pascual, Pedro Seoane, James Richard Perkins, Juan A. G. Ranea, Segun Fatumo, Tamas Douglas Korcsmaros, José Manuel Martín‐Villa et al. · 2023 · iScience
  54. Potential role of IgM-enriched immunoglobulin as adjuvant treatment in severe SARS-CoV-2 infection
    Carlo Tascini, Marco Cotrufo, Emanuela Sozio, Matteo Fanin, Fabiana Dellai, Agnese Zanus-Fortes, Daniela Cesselli, Paola De Stefanis, Andrea Ripoli, Francesco Sbrana et al. · 2023 · Minerva Anestesiologica
  55. Bronchial Asthma and COVID-19: Etiology, Pathological Triggers, and Therapeutic Considerations
    Anna Andreevna Starshinova, Anastasiia A. Borozinets, Anastasia Kulpina, Vitaliy Sereda, Artem Rubinstein, Igor Vladimirovich Kudryavtsev, Dmitry Anatolievich Kudlay · 2024 · Pathophysiology
  56. Shared neutrophil and T cell dysfunction is accompanied by a distinct interferon signature during severe febrile illnesses in children
    Harsita Patel, Michael James Carter, Heather Jackson, Oliver Powell, Matthew Fish, Manuela Terranova-Barberio, Filomena Spada, Nedyalko Petrov, Paul Wellman, Sarah Darnell et al. · 2024 · Nature Communications
  57. Inflammatory pathways and potential therapies for COVID-19: A mini review
    Areeg M. Dabbish, Nouran Yonis, Mohamed Salama, Musthafa Mohamed Essa, M. Walid Qoronfleh · 2021 · European Journal of Inflammation
  58. Landscape of Peripheral Blood Mononuclear Cells and Soluble Factors in Severe COVID-19 Patients With Pulmonary Fibrosis Development
    Zhuolin Wang, Yang Zhang, Rirong Yang, Yujia Wang, Jiapei Guo, Ruya Sun, Yuan M. Zhou, Su Li, Qing Ge, Yingmei Feng · 2022 · Frontiers in Immunology
  59. Tocilizumab Accelerates Recovery in Patients With Severe COVID-19 Pneumonia on Venovenous Extracorporeal Membrane Oxygenation
    Tyler C. Lewis, Serena Arnouk, Bridget Toy, Travis C. Geraci, Julius A. Carillo, Stephanie H. Chang, Nader Moazami, Zachary N. Kon, Deane E. Smith · 2022 · ASAIO Journal
  60. Mass versus personalized medicine against COVID ‐19 in the “system sciences” era
    Laura Teodori, Barbara Osimani, Ciro Isidoro, Seeram Ramakrishna · 2022 · Cytometry Part A
  61. Left atrial strain is associated with distinct inflammatory and immune profile in patients with COVID-19 pneumonia
    Filipe André Gonzalez, Miguel Ângelo‐Dias, Catarina Gregório Martins, Rui M. Gomes, Jacobo Bacariza Blanco, Antero Fernandes, Luís Miguel Borrego, EchoCrit Group · 2023 · The Ultrasound Journal
  62. T cell maturation is significantly affected by SARS‐CoV ‐2 infection
    Laura Otto Walter, Chandra Chiappin Cardoso, Íris Mattos Santos‐Pirath, Heloísa Zorzi Costa, Rafaela Gartner, Isabel Werle, Eduarda Talita Bramorski Mohr, Júlia Salvan da Rosa, Tainá Larissa Lubschinski, Mariano Felisberto et al. · 2023 · Immunology
  63. Peptides of H. sapiens and P. falciparum that are predicted to bind strongly to HLA-A*24:02 and homologous to a SARS-CoV-2 peptide
    Yekbun Adıgüzel · 2021 · Acta Tropica
  64. Immunomodulatory therapy for the management of critically ill patients with COVID-19: A narrative review
    David Andaluz‐Ojeda, Pablo Vidal, Álvaro Aparisi Sanz, Borja Suberviola, Lorena del Río Carbajo, Leonor Nogales Martín, Estefanía Prol Silva, Jorge Nieto-del Olmo, José Barberán, Iván Cusácovich · 2022 · World Journal of Critical Care Medicine
  65. Human endogenous retrovirus K activation in the lower respiratory tract of severe COVID-19 patients associates with early mortality
    Thiago Moreno L. Souza, Jairo Ramos Temerozo, Natalia Fintelman Rodrigues, Monique Cristina dos Santos, Eugênio Damaceno Hottz, Carolina Q. Sacramento, Aline Silva, Samuel Coelho Mandacaru, Emilly Caroline dos Santos Moraes, Monique R. O. Trugilho et al. · 2021 · Research Square
  66. Impact of message fatigue and individual behavioral responses on epidemiological spread in temporal simplicial networks
    Xiao-Nan 晓楠 Fan 樊, Xuemei 雪梅 You 由 · 2025 · Chinese Physics B
  67. Pulmonary embolism following an undiagnosed Paget-Schroetter syndrome: a case report and review of the literature
    Alexandre Negrão Pantaleão, Guillaume Goudot, Luca Becari, Vinícius Ribeiro Jeunon, Guilherme Andrade Bello, Alice Gallo de Moraes · 2023 · The Physician and Sportsmedicine
  68. Unbiased plasma profiling using pre-selected RNA aptamer pools predicts mortality in COVID-19 and identifies protein risk factors
    Asger Givskov Jørgensen, Daniel M. Dupont, Søren Fjelstrup, Claus Bus, Cecilie Bo Hansen, Thomas Benfield, Peter Garred, Peter M. H. Heegaard, Jørgen Kjems · 2024 · Molecular Therapy — Nucleic Acids
  69. Time-dependent contraction of the SARS-CoV-2–specific T-cell responses in convalescent individuals
    Edgar Ruz Fernandes, Juliana de Souza Apostólico, Lucas Cauê Jacintho, Maria Lúcia Carnevale Marin, Roberto Carlos Vieira da Silva Júnior, Helcio Rodrigues, Keity Souza Santos, Verônica P.C.V. Coelho, Silvia Beatriz Boscardin, Jorge Elias Kalil et al. · 2022 · Journal of Allergy and Clinical Immunology Global
  70. Histology and cytokine levels in hepatic injury accompanying a case of non-severe COVID-19
    Hidetaka Matsuda, Takuto Nosaka, Katsushi Hiramatsu, Kazuto Takahashi, Tatsushi Naito, Kazuya Ofuji, Masahiro Ohtani, Yoshiaki Imamura, Hiromichi Iwasaki, Yasunari Nakamoto · 2023 · Clinical Journal of Gastroenterology
  71. Proof-of-concept for effective antiviral activity of an in silico designed decoy synthetic mRNA against SARS-CoV-2 in the Vero E6 cell-based infection model
    Nofar Atari, Oran Erster, Yair Heskiau Shteinberg, Hadar Asraf, Eitan Giat, Michal Mandelboim, Itamar Goldstein · 2023 · Frontiers in Microbiology
  72. L-Arginine in Restoring ‘Immune Dysregulation’ in Long COVID: It’s the Therapeutic Role Beyond the Routine Dietary Supplement!
    Shital Manoj Patil, Swati Patil, Gajanan Gondhali · 2023 · South Asian Research Journal of Applied Medical Sciences
  73. Anti-synthetase syndrome is associated with a higher risk of hospitalization among patients with idiopathic inflammatory myopathy and COVID-19
    Wanlong Wu, Runci Wang, Cuiying Xie, Yi Chen, Xiangyu Teng, Shuhui Sun, Wenwen Xu, Yakai Fu, Yiyangzi Ma, Antao Xu et al. · 2024 · Frontiers in Immunology
  74. Impact of asymptomatic infected individuals on epidemic transmission dynamics in multiplex networks with partial coupling
    Xin 鑫 Hu 胡, Jiaxing 嘉兴 Chen 陈, Chengyi 承遗 Xia 夏 · 2024 · Chinese Physics B
  75. Impact of antiplatelets, anticoagulants and cyclic nucleotide stimulators on neutrophil extracellular traps (NETs) and inflammatory markers during COVID-19
    José Diogo Oliveira, Gislaine Vieira‐Damiani, Letícia Queiroz da Silva, Guilherme Ruiz Leonardi, Camila de Oliveira Vaz, Bruna Cardoso Jacintho, Bruna de Moraes Mazetto, Erich Vinícius De Paula, Fabíola Z. Mónica, Fernanda Andrade Orsi · 2024 · Journal of Thrombosis and Thrombolysis
  76. Cheap and Commonplace: Making the Case for BCG and γδ T Cells in COVID-19
    Alexandra L. Morrison, Sally A. Sharpe, Andrew White, Mark D. Bodman‐Smith · 2021 · Frontiers in Immunology
  77. Immunological Biomarkers in Blood to Monitor the Course and Therapeutic Outcomes of COVID-19
    Eberhard Wieland · 2021 · Therapeutic Drug Monitoring
  78. An ultrasensitive and long-lasting chemiluminescence immunoassay for IP-10 detection based on a 4-bromophenol-reinforced bienzymatic system
    Jiang Chang, Deying Zou, Honglin Ren, Xilin Liu, Meng Li, Zhaozhao Si, Han Cheng, Zengshan Liu, Shiying Lu, Pan Hu · 2022 · Microchemical Journal
  79. Cellular immunity in patients with COVID-19: molecular biology, pathophysiology, and clinical implications
    Sergey G. Sсherbak, Dmitry A. Vologzhanin, Александр Сергеевич Голота, Тatyana A. Kamilova, Станислав Вячеславович Макаренко · 2022 · Journal of clinical practice
  80. SARS‐CoV‐2 Infection in Pediatric Solid Organ Transplant Recipients
    Saikat Paul, Scott Royal, Margaret Lee, Stephanie Shin, Joeffrey J. Chahine, Aaron M. Rozeboom, Jaeil Ahn, Harmeet Dhani, Nada A. Yazigi, Stuart S. Kaufman et al. · 2022 · Journal of Pediatric Gastroenterology and Nutrition
  81. Immune profile of children diagnosed with multisystem inflammatory syndrome associated with SARS-CoV-2 infection (MIS-C)
    Ewelina Gowin, Grzegorz Dworacki, Bartosz Siewert, Jacek Wysocki, Danuta Januszkiewicz‐Lewandowska · 2022 · Central European Journal of Immunology
  82. Strong Humoral but Not Cellular Immune Responses against SARS-CoV-2 in Individuals with Oncohematological Disease Who Were Treated with Rituximab before Receiving a Vaccine Booster
    Montserrat Torres, Magdalena Corona, Sara Rodríguez-Mora, Guiomar Casado‐Fernández, Alejandro Zurdo-Castronuño, Elena Mateos, Fernando Ramos-Martín, Clara Sánchez-Menéndez, María Aránzazu Murciano-Antón, Javier García‐Pérez et al. · 2022 · Cancers
  83. Vaccination status for mild and asymptomatic infections with SARS‐CoV‐2 Omicron BA.2 variant in Shanghai
    Yong Yin, Jilei Lin, Shuhua Yuan, Shilu Tong, Yi He, Bin Dong, Fen Zhang, Erzhen Chen, Junhua Zheng, Wei J. Wang · 2023 · Journal of Medical Virology
  84. To be remembered: B cell memory response against SARS‐CoV ‐2 and its variants in vaccinated and unvaccinated individuals
    Nafees Ahmed, Atharv Athavale, Ankita Harishchandra Tripathi, Adarsh Subramaniam, Santosh Kumar Upadhyay, Anil Kumar Pandey, Ramesh Chandra Rai, Amit Awasthi · 2023 · Scandinavian Journal of Immunology
  85. NT-proBNP ratio is a potential predictor for COVID-19 outcomes in adult Chinese patients: a retrospective study
    Dan Li, Wu He, Bo Yu, Dao Wen Wang, Ni Li · 2024 · Scientific Reports
  86. Comprehensive analysis of immunogenic cell death-related gene and construction of prediction model based on WGCNA and multiple machine learning in severe COVID-19
    Chunyu Li, Ke Wu, Rui Yang, Minghua Liao, Jun Li, Qian Zhu, Jiayi Zhang, Xianming Zhang · 2024 · Scientific Reports
  87. Molecular Insights into the Crosstalk Between Immune Inflammation Nexus and SARS-CoV-2 Virus
    Pritha Bose, Priyashree Sunita, Shakti Prasad Pattanayak · 2021 · Current Microbiology
  88. Elevated cytokines and chemokines in peripheral blood of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma
    Stacey L. Fanning, Robert Korngold, Zheng Rong Yang, Kira Goldgirsh, Steven Park, Joshua Zenreich, Melissa Baker, Phyllis McKiernan, Ming Tony Tan, Bingsong Zhang et al. · 2021 · PLoS Pathogens
  89. T cell receptor repertoire signatures associated with COVID-19 severity
    Jonathan Joon-Young Park, Kyoung A. Viola Lee, Stanley Z. Lam, Sidi Chen · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  90. Response
    Giacomo Grasselli, Vittorio Scaravilli, Davide Mangioni, Luigia Scudeller, Laura Alagna, Andrea Gori, Alessandra Bandera · 2021 · CHEST Journal
  91. Early Treatment, Inflammation and Post-COVID Conditions
    Kelly A. Gebo, Sonya L. Heath, Yuriko Fukuta, Xianming Zhu, Sheriza N. Baksh, Alison G. Abraham, Feben Habtehyimer, David M. Shade, Jessica E. Ruff, Malathi Ram et al. · 2023 · medRxiv
  92. Stroke-induced changes to immune function and their relevance to increased risk of severe COVID-19 disease
    Laura J. McCulloch, Isobel C. Mouat, Kieron South, Barry W. McColl, Stuart McRae Allan, Craig J. Smith · 2022 · Discovery Immunology
  93. POST-COVID EFFECTS AND IMMUNOLOGICAL MARKERS OF AGING
    Iryna Kril, Valentyna V. Chopyak, Nataliia Melnykova, Andriy Bazylevych, Nataliya Shakhovska · 2024 · Proceedings of the Shevchenko Scientific Society Medical Sciences
  94. Immune Profiling to Determine Early Disease Trajectories Associated With Coronavirus Disease 2019 Mortality Rate: A Substudy from the ACTT-1 Trial
    Joshua M. Thiede, Abigail R. Gress, Samuel D Libby, Christine E. Ronayne, William E. Matchett, Brooke Noren, Joanne L. Billings, Vineet D. Menachery, Ryan Andrew Langlois, Susan Kline et al. · 2021 · The Journal of Infectious Diseases
  95. Impact of the COVID-19 Pandemic on Oncology Patients’ Mental Health and Treatment Plans
    Arwa Althumairi, Entesar Ahmed Al Askari, Reem S. AlOmar, Arwa Khalid Alumran · 2022 · Healthcare
  96. Cardiac megakaryocytes in SARS‐CoV ‐2‐positive autopsies
    Kara L. Gawelek, Robert F. Padera, Jean M. Connors, Geraldine S. Pinkus, Olga Podznyakova, Elisabeth M. Battinelli · 2022 · Histopathology
  97. SARS‐CoV‐2 variants of concern elicit divergent early immune responses in hACE2 transgenic mice
    Charlie Fricke, Florian Pfaff, Lorenz Ulrich, Nico Joël Halwe, Jacob Schön, Laura Timm, Weda Hoffmann, Susanne Rauch, Benjamin Petsch, Donata Hoffmann et al. · 2023 · European Journal of Immunology
  98. Broad spectrum SARS‐CoV ‐2‐specific immunity in hospitalized First Nations peoples recovering from COVID ‐19
    Wuji Zhang, E. Bridie Clemens, Łukasz Kedzierski, Brendon Yew Loong Chua, Mark J. Mayo, Claire Lonzi, Alexandra Hinchcliff, Vanessa Rigas, Bianca F. Middleton, Paula Binks et al. · 2023 · Immunology and Cell Biology
  99. Lymphocyte B Subtypes in Peripheral Blood: A Prognostic Biomarker for COVID-19 Patients
    Mariano Felisberto, Laura Otto Walter, Chandra Chiappin Cardoso, Íris Mattos Santos‐Pirath, Heloísa Zorzi Costa, Rafaela Gartner, Isabel Werle, Eduarda Talita Bramorski Mohr, Júlia Salvan da Rosa, Tainá Larissa Lubschinski et al. · 2024 · The Journal of Applied Laboratory Medicine
  100. Early immune profiling reveals distinct inflammatory responses between children and adults few days after primary SARS-CoV-2 infection
    Martijn D. B. van de Garde, Alberto Miranda Bedate, Nening M. Nanlohy, Ronald H. J. Jacobi, Adam Meijer, Daphne F. M. Reukers, Josine van Beek, Cécile A. C. M. van Els, Debbie van Baarle, Nynke Y. Rots et al. · 2024 · Frontiers in Immunology